HOOK: Nilai perusahaan marang bathi resik hookipapharma.com
HOOKIPA Pharma Inc. (HOOK) revenues are based on payments from strategic partners and the commercialization of Vaxwave therapy. Simultaneously, the company is implementing energy-efficient laboratory solutions to minimize harmful emissions. Currently, the R&D center is testing promising immune drugs for oncology. The current PE ratio stands at -0.10, which is detailed in the company's price chart.
%20Pangali%20P%2FE&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_HOOK_-_HOOKIPA-Pharma-Inc._-_PE-Multiple "HOOK: Periode bali modal bisnis HOOKIPA 04.07.2022 - 16.08.2025 | 👁️GURU.Markets👁️")
Rincian analitis perusahaan HOOKIPA Pharma, Inc. (HOOK)
- rega lan prakiraan konsensus rega:
- informasi kapitalisasi pasar:
- indikator nilai aset resik miturut neraca:
- informasi babagan utang lan solvabilitas:
Rasio Total Utang marang Ekuitas HOOKIPA Pharma Inc.|HOOK - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal HOOKIPA|HOOK - Utang perusahaan|Rasio utang marang nilai buku HOOKIPA Pharma Inc.|HOOK - Utang jangka dawa perusahaan|Utang jangka cendhak HOOKIPA Pharma|Rasio jangkoan perantara hookipapharma.com
- rincian bathi lan kelipatan pasar:
HOOK - Bathi resik perusahaan|Bathi resik sing dikarepake HOOKIPA Pharma Inc.|HOOK - Rasio rega marang bathi|Rasio prakiraan rega marang bathi HOOKIPA|HOOK - Rasio rega marang bathi tumrap wutah|Pangali EV/EBITDA HOOKIPA Pharma Inc.|HOOK - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan HOOKIPA Pharma|HOOK - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan hookipapharma.com|HOOK - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep HOOKIPA Pharma Inc.
Analisis komprehensif perusahaan:hookipapharma.com HOOK
Defensive assets are selected based on the stability of their fundamental indicators. HOOKIPA Pharma Inc. (HOOK) demonstrates this standard through competent management that optimizes capital expenditure via strategic alliances. The ratio of market capitalization to net income, reflected in the company's forward P/E, measures the cost of one unit of profit. This indicator determines the degree of overpayment for future growth. The price action of the curve allows for an assessment of market expectations regarding the efficiency of biotechnological developments.
Pesaing wigati
Pangali P/E argenx.com|Koefisien rega marang bathi BNTX (BioNTech)|ABVX (ABIVAX) - Nilai perusahaan marang bathi resik|Pangali P/E ADMA (ADMA Bio)|Periode bali modal bisnis Protagonist Corp (PTGX)|IMVT - Rasio rega marang bathi|kiniksa.com (KNSA) - Koefisien rega marang bathi|Grifols (GRFS) - Rasio rega marang bathi|Koefisien rega marang bathi Adaptive Biotech|Koefisien rega marang bathi CLDX|Pangali P/E Aurinia Corp|Rasio rega marang bathi BioCryst (BCRX)|veratx.com - Pangali rega marang bathi|Pangali P/E DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalisasi marang bathi|AbCellera Bio - Pangali P/E|Nilai perusahaan marang bathi resik TRML (Tourmaline)|Precigen, Inc. (PGEN) - Rasio rega marang bathi|Kapitalisasi marang bathi pharming.com (PHAR)|Rasio rega marang bathi Nektar Therapeutics Inc.|Kapitalisasi marang bathi Upstream Bio, Inc. UPB|Rasio rega marang bathi Zenas Biopharma, Inc. (ZBIO)|Pangali P/E Immunome Bio (IMNM)|Pangali P/E GOSS (Gossamer Bio, Inc.)|Periode bali modal bisnis kalvista.com (KALV)|SEPN - Rasio rega marang bathi|Kapitalisasi marang bathi resik PVLA|SVRA: Pangali P/E|Rigel Corp (RIGL) - Pangali P/E|Koefisien rega marang bathi ANAB|ATXS: Nilai perusahaan marang bathi resik|Rasio rega marang bathi enGene (ENGN)|RAPT: Kapitalisasi marang bathi resik|Pangali P/E JBIO (Aerovate Therapeutics)|Nilai perusahaan marang bathi resik ACRS|Kyverna Therapeutics - Pangali P/E|TLSA - Pangali P/E|Cabaletta Bio (CABA) - Rasio rega marang bathi|Ventyx Biosciences Inc. - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Theratechnologies Inc|Koefisien rega marang bathi Avalo Therapeutics Inc (AVTX)|Pangali P/E ELDN|Pangali P/E agenusbio.com (AGEN)|Climb Bio - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik ZURA|aTyr - Pangali P/E|Periode bali modal bisnis Adagene ADAG|ikenaoncology.com (IMA) - Rasio rega marang bathi|Pangali rega marang bathi STTK|EQ (Equillium Inc) - Pangali P/E|Koefisien rega marang bathi Connect Pharma (CNTB)|Koefisien rega marang bathi IMUX (Immunic, Inc.)|Periode bali modal bisnis atarabio.com|Pangali P/E IFRX (InflaRx)|Nilai perusahaan marang bathi resik XFOR|ACET - Rasio rega marang bathi|Kapitalisasi marang bathi Celularity Inc.|INmune Bio Corp (INMB) - Rasio rega marang bathi|Kapitalisasi marang bathi Barinthus Biotherapeutics Corp (BRNS)|Rasio rega marang bathi Kezar Life Sciences|Pangali P/E sabbiotherapeutics.com|Rasio rega marang bathi Akari Therapeutics Plc (AKTX)|ENLV: Kapitalisasi marang bathi resik|Pangali P/E QTTB (Q32 Bio)|Nilai perusahaan marang bathi resik GOVX|Edesa Biotech, Inc. - Pangali P/E|IBIO - Pangali P/E|carismatx.com (CARM) - Rasio rega marang bathi|XTL Biopharmaceuticals Ltd - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Bolt Biotherapeutics Inc.|Koefisien rega marang bathi HCW Biologics Inc (HCWB)|Pangali P/E APVO|Pangali P/E AIM ImmunoTech, Inc. (AIM)|Aditxt, Inc. - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik GRI|XORTX - Pangali P/E|Periode bali modal bisnis Vyome Therapeutics HIND|Revelation Biosciences (REVB) - Rasio rega marang bathi|Koefisien rega marang bathi indaptusrx.com|Rasio rega marang bathi Scinai Immunotherapeutics Ltd.|Koefisien rega marang bathi CalciMedica Corp (CALI)|Koefisien rega marang bathi AFMD (Affimed)|Pangali P/E allakos.com (ALLK)|Rasio rega marang bathi IGM Biosciences IGMS|ITOS: Pangali rega marang bathi|Ocean Biomedical - Pangali P/E|Kapitalisasi marang bathi TC BioPharm (Holdings) Plc|THRD: Pangali P/E
